Penserra Capital Management LLC Cybin Inc. Transaction History

Penserra Capital Management LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.41 - $0.88 $13,539 - $29,061	-33,024 Reduced 8.11%	374,285 $209,000
Q1 2022 May 13, 2022	BUY	$0.74 - $1.22 $107,987 - $178,033	145,929 Added 55.83%	407,309 $223,000
Q4 2021 Feb 15, 2022	BUY	$1.13 - $2.31 $56,231 - $114,950	49,762 Added 23.52%	261,380 $313,000
Q3 2021 Nov 15, 2021	BUY	$1.83 - $3.18 $387,260 - $672,945	211,618 New	211,618 $463,000

66.1K

Ticker CYBN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 166,120,000
Market Cap $1.58B
Description
Cybin Inc., a biopharmaceutical company, focuses on developing psychedelic-based therapeutics. The company's development pipeline includes CYB003, a deuterated psilocybin analog to treat major depressive and alcohol use disorders; CYB004, a deuterated dimethyltryptamine for treating anxiety disorders; and CYB005, a phenethylamine derivative to t...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.